CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.39−0.96 (-1.95%)
Close on Nov 17, 2026Market cap $1.44BP/E 20.0Yield 1.24%
Conmed total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Conmed's total debt was $815.87M at Sep 30, 2026. For fiscal 2025 it was $834.94M, down 7.8% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $1.05B in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $834.94M | -7.8% |
| FY2024 | Dec 31, 2024 | $905.78M | -7.0% |
| FY2023 | Dec 31, 2023 | $973.85M | -7.7% |
| FY2022 | Dec 31, 2022 | $1.05B | +54.1% |
| FY2021 | Dec 31, 2021 | $684.66M | -9.2% |
| FY2020 | Dec 31, 2020 | $753.64M | -2.0% |
| FY2019 | Dec 31, 2019 | $768.81M | +68.3% |
| FY2018 | Dec 31, 2018 | $456.90M | -6.1% |
| FY2017 | Dec 31, 2017 | $486.44M | -2.4% |
| FY2016 | Dec 31, 2016 | $498.49M | +84.1% |
| FY2015 | Dec 31, 2015 | $270.81M | +12.2% |
| FY2014 | Dec 31, 2014 | $241.44M | +12.0% |
| FY2013 | Dec 31, 2013 | $215.58M | +33.2% |
| FY2012 | Dec 31, 2012 | $161.85M | +12.8% |
| FY2011 | Dec 31, 2011 | $143.51M | -26.6% |
| FY2010 | Dec 31, 2010 | $195.62M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $815.87M | -4.4% |
| Q2 FY2026 | Jun 30, 2026 | $834.25M | -5.4% |
| Q1 FY2026 | Mar 31, 2026 | $860.87M | -3.5% |
| Q4 FY2025 | Dec 31, 2025 | $834.94M | -7.8% |
| Q3 FY2025 | Sep 30, 2025 | $853.75M | -9.3% |
| Q2 FY2025 | Jun 30, 2025 | $881.83M | -8.7% |
| Q1 FY2025 | Mar 31, 2025 | $892.16M | -10.0% |
| Q4 FY2024 | Dec 31, 2024 | $905.78M | -7.0% |
| Q3 FY2024 | Sep 30, 2024 | $940.81M | -7.1% |
| Q2 FY2024 | Jun 30, 2024 | $965.89M | -7.2% |
| Q1 FY2024 | Mar 31, 2024 | $990.80M | -7.0% |
| Q4 FY2023 | Dec 31, 2023 | $973.85M | -7.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.01B | -2.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.04B | +5.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.06B | +48.8% |
| Q4 FY2022 | Dec 31, 2022 | $1.05B | +54.1% |
| Q3 FY2022 | Sep 30, 2022 | $1.04B | +44.9% |
| Q2 FY2022 | Jun 30, 2022 | $982.70M | +34.7% |
| Q1 FY2022 | Mar 31, 2022 | $715.77M | -4.0% |
| Q4 FY2021 | Dec 31, 2021 | $684.66M | -9.2% |
| Q3 FY2021 | Sep 30, 2021 | $715.59M | -7.9% |
| Q2 FY2021 | Jun 30, 2021 | $729.68M | -9.4% |
| Q1 FY2021 | Mar 31, 2021 | $745.40M | -5.2% |
| Q4 FY2020 | Dec 31, 2020 | $753.64M | -2.0% |
| Q3 FY2020 | Sep 30, 2020 | $777.26M | -2.1% |
| Q2 FY2020 | Jun 30, 2020 | $805.62M | -0.5% |
| Q1 FY2020 | Mar 31, 2020 | $786.20M | -3.9% |
| Q4 FY2019 | Dec 31, 2019 | $768.81M | +68.3% |
| Q3 FY2019 | Sep 30, 2019 | $794.17M | +72.3% |
| Q2 FY2019 | Jun 30, 2019 | $809.66M | +80.3% |
| Q1 FY2019 | Mar 31, 2019 | $817.94M | +78.5% |
| Q4 FY2018 | Dec 31, 2018 | $456.90M | -6.1% |
| Q3 FY2018 | Sep 30, 2018 | $460.95M | -9.3% |
| Q2 FY2018 | Jun 30, 2018 | $449.19M | -9.5% |
| Q1 FY2018 | Mar 31, 2018 | $458.20M | -8.1% |
| Q4 FY2017 | Dec 31, 2017 | $486.44M | -2.4% |
| Q3 FY2017 | Sep 30, 2017 | $508.33M | – |
| Q2 FY2017 | Jun 30, 2017 | $496.48M | – |
| Q1 FY2017 | Mar 31, 2017 | $498.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $498.49M | – |
See a number that looks wrong?